XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
  IBS
  Liver
  GERD
  Constipation
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Gastroenterology Channel
subscribe to Gastroenterology newsletter

Latest Research : Gastroenterology

   DISCUSS   |   EMAIL   |   PRINT
Cholesterol regulating Liver X Receptors (LXR) maintain Fat Levels
Apr 13, 2005, 20:01, Reviewed by: Dr.

�In the animals lacking LXR, not only can they not store fat, but their cholesterol concentrations build to excessive levels, which somehow drives the animals to burn fat. There is some cholesterol-related signal that the liver sends out that permits fat-burning to happen, and uncovering that signal is the big mystery we�re trying to solve next, which may have therapeutic applications.�

 
A protein that regulates cholesterol levels in the body also is responsible for maintaining a healthy balance between fat storage and fat burning, according to a UT Southwestern Medical Center study that may lead to new drug targets in the fight against obesity.

In animals and humans, a protein called the liver X receptor, or LXR, senses cholesterol levels. When these receptors detect rising amounts of cholesterol, they activate genes and a series of biochemical reactions that remove diet-derived cholesterol from the body.

The cholesterol-regulating role of LXRs is well understood, but until now, their role in regulating fat levels was unclear.

In their recent study, UT Southwestern researchers found that �knockout� mice genetically engineered to lack the gene for LXR could not store fat and did not become obese when they were fed a Western-style diet high in both fat and cholesterol. However, knockout mice fed only fat were able to store fat.

High-fat diets typically contain both fat and cholesterol, but this study shows that it is the cholesterol component of a high-fat diet that actually triggers the normal fat-storage process in the body, said Dr. David Mangelsdorf, professor of pharmacology and biochemistry at UT Southwestern and senior author of the study.

�Our studies suggest a dual role for LXRs,� said Dr. Mangelsdorf, an investigator in the Howard Hughes Medical Institute at UT Southwestern. �Not only do these receptors sense and limit the accumulation of dietary cholesterol, but their activation by cholesterol is required to initiate a major fat-storing process.�

Because the knockout mice cannot remove excess dietary cholesterol, the animals develop extremely high cholesterol levels.

Surprisingly, the researchers found that the buildup of cholesterol in the knockout mice actually activates a fat-burning process, a finding that provided more evidence of the role LXR plays in regulating the balance between fat burning and fat storage.

�In the animals lacking LXR, not only can they not store fat, but their cholesterol concentrations build to excessive levels, which somehow drives the animals to burn fat,� said Dr. Mangelsdorf, who holds the Doris and Bryan Wildenthal Distinguished Chair in Medical Science. �There is some cholesterol-related signal that the liver sends out that permits fat-burning to happen, and uncovering that signal is the big mystery we�re trying to solve next, which may have therapeutic applications.�

A better understanding of the cholesterol-driven, fat-burning signal may lead to drugs that control the signal and boost the body�s ability to burn unwanted fat instead of storing it, Dr. Mangelsdorf said. The research also may aid in the development of cholesterol-related drugs. High levels of low-density lipoproteins, or �bad� cholesterol, in humans is a major risk factor for heart disease, heart attack and stroke because it contributes to the buildup of plaque that clogs the walls of arteries.

Previous studies have pointed to a protein called SREBP-1c as the primary component in the biochemical pathway that regulates fat metabolism. When an animal eats a meal rich in nutrients, insulin levels in its body go up. Insulin signals to the SREBP-1c protein to activate subsequent components of the pathway, allowing the body to store incoming nutrients as fat.

But Dr. Mangelsdorf�s research group has shown that LXRs actually regulate SREBP-1c, activating the gene responsible for making the SREBP-1c protein in the first place. �LXR, this cholesterol sensor, is required for SREBP-1c to be expressed, to get SREBP-1c to initiate its role in regulating fat storage,� said Dr. Mangelsdorf, who discovered the LXR protein and the gene responsible for making it. �SREBP-1c had been considered the master regulator of fat synthesis, but our studies have shown that LXR is the master regulator of the master regulator.�

From the point of view of evolution, an animal capable of linking its ability to sense cholesterol with its ability to store fat may have had a survival advantage. An adult mammal has virtually no need for dietary cholesterol because its body can synthesize enough on its own. But LXRs give an animal the ability to sense the cholesterol component of a high-fat diet and get rid of it, while retaining the fat and storing it for times of deprivation.

�Our work suggests that fat storage is inextricably linked to the body�s ability to metabolize cholesterol and that the LXRs have evolved as the sensors that govern the unique cross talk between these two important metabolic pathways,� Dr. Mangelsdorf said.
 

- The research appears in the April issue of the journal Cell Metabolism.
 

www.utsouthwestern.edu

 
Subscribe to Gastroenterology Newsletter
E-mail Address:

 

Other UT Southwestern researchers involved in the study were Dr. Nada Kalaany, postdoctoral researcher in pharmacology; Dr. Karine Gauthier former postdoctoral fellow; Dr. Pradeep Mammen, assistant professor of internal medicine; Dr. Tatsuya Kitazume, biochemistry postdoctoral researcher; Dr. Julian Peterson, professor of biochemistry; Dr. Jay Horton, associate professor of internal medicine and molecular genetics; and Dr. Daniel Garry, associate professor of internal medicine and molecular biology. Researchers at Harvard Medical School also participated. The work was funded by the Howard Hughes Medical Institute, the Robert A. Welch Foundation and the National Institutes of Health.

Related Gastroenterology News

British scientists create artificial stomach
Researchers find a gene variant that protects against development of IBD
MR Elastography may help in early diagnosis of liver fibrosis
Lactose intolerance does not mean total avoidance of dairy foods
Why does prolonged IV feeding damage the liver?
Oral enzyme therapy for celiac sprue may mean less dietary restrictions
Coffee may reduce risk of alcoholic cirrhosis
Benefits of Polyflex Esophageal Stents For Treating Refractory Benign Esophageal Strictures
Novel visualization by SpyGlass System may reduce repeat ERCP procedures
Endoscopic clips useful in patients on coumadin anticoagulation therapy undergoing colonoscopy


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us